• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6对人肝癌细胞中去γ-羧基凝血酶原合成的影响。

The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells.

作者信息

Ono M, Kohda H, Naraki T, Ohta H, Ohhira M, Sekiya C, Namiki M

机构信息

Third Department of Internal Medicine, Asahikawa Medical College, Japan.

出版信息

Gastroenterol Jpn. 1992 Dec;27(6):745-50. doi: 10.1007/BF02806527.

DOI:10.1007/BF02806527
PMID:1334890
Abstract

Effects of several cytokines on des-gamma-carboxy prothrombin (PIVKA II) synthesis in human hepatoma cells were investigated to know the process of PIVKA II production during a liver allograft rejection. Human recombinant interleukin-6 (IL-6) significantly stimulated the PIVKA II synthesis without any influence on the cell proliferation. The effect was almost completely neutralized by the specific anti-IL-6 antibody. Neither tumor necrosis factor (TNF), interleukin-1 (IL-1) nor interferon-gamma (IFN-gamma) had such a stimulative effect. IL-6 appears to stimulate PIVKA II production, and would be a candidate of factors that enhance the production of PIVKA II during a liver allograft rejection.

摘要

研究了几种细胞因子对人肝癌细胞中去γ-羧基凝血酶原(PIVKA II)合成的影响,以了解肝移植排斥反应期间PIVKA II的产生过程。人重组白细胞介素-6(IL-6)显著刺激PIVKA II的合成,而对细胞增殖没有任何影响。该作用几乎完全被特异性抗IL-6抗体中和。肿瘤坏死因子(TNF)、白细胞介素-1(IL-1)和干扰素-γ(IFN-γ)均无这种刺激作用。IL-6似乎刺激PIVKA II的产生,并且可能是在肝移植排斥反应期间增强PIVKA II产生的因子之一。

相似文献

1
The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells.白细胞介素-6对人肝癌细胞中去γ-羧基凝血酶原合成的影响。
Gastroenterol Jpn. 1992 Dec;27(6):745-50. doi: 10.1007/BF02806527.
2
Detection of PIVKA II produced by human hepatoma cells in nude mice.裸鼠中人肝癌细胞产生的异常凝血酶原II的检测。
Hum Cell. 1991 Mar;4(1):63-6.
3
Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.肝细胞癌组织中维生素K、免疫反应性凝血酶原、去γ-羧基凝血酶原及γ-谷氨酰羧化酶活性水平
J Gastroenterol Hepatol. 1995 Jan-Feb;10(1):8-13. doi: 10.1111/j.1440-1746.1995.tb01040.x.
4
Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells.肿瘤坏死因子、白细胞介素-1和白细胞介素-6对人肝癌细胞中锰超氧化物歧化酶的诱导作用。
Biochem Biophys Res Commun. 1992 Feb 14;182(3):1100-7. doi: 10.1016/0006-291x(92)91845-h.
5
The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.维生素K对肝细胞癌患者去γ-羧基凝血酶原(异常凝血酶原-II)生成的影响。
Am J Gastroenterol. 1991 Mar;86(3):339-45.
6
Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
Am J Gastroenterol. 1990 Sep;85(9):1149-54.
7
Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.上皮细胞向成纤维样细胞转化过程中的细胞骨架变化是肝细胞癌中去γ-羧基凝血酶原产生的关键机制。
Int J Oncol. 2009 Nov;35(5):1005-14. doi: 10.3892/ijo_00000415.
8
Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia.肝细胞癌和腺瘤样增生中异常凝血酶原-II表达的组织学研究
Pathol Int. 2001 Dec;51(12):916-22. doi: 10.1046/j.1440-1827.2001.01296.x.
9
Immunohistochemical study of protein induced by vitamin K absence or antagonist II in hepatocellular carcinoma.维生素K缺乏或拮抗剂II诱导蛋白在肝细胞癌中的免疫组织化学研究
J Surg Oncol. 2003 Oct;84(2):89-93. doi: 10.1002/jso.10298.
10
Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.血浆去γ-羧基凝血酶原作为不同大小肿瘤患者肝细胞癌标志物蛋白的临床评价。
Dig Dis Sci. 1993 Dec;38(12):2170-6. doi: 10.1007/BF01299891.

本文引用的文献

1
Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone.两种新型人肝癌细胞系产生乙肝表面抗原及其受地塞米松的增强作用
Gan. 1981 Feb;72(1):178-9.
2
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.去γ-羧基(异常)凝血酶原作为原发性肝细胞癌的血清标志物
N Engl J Med. 1984 May 31;310(22):1427-31. doi: 10.1056/NEJM198405313102204.
3
Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin.通过使用酶联免疫吸附测定法检测循环中的异常凝血酶原以诊断维生素K缺乏症。
Pediatr Res. 1985 Apr;19(4):354-7. doi: 10.1203/00006450-198519040-00008.
4
Vitamin K-dependent carboxylase.维生素K依赖性羧化酶
Annu Rev Biochem. 1985;54:459-77. doi: 10.1146/annurev.bi.54.070185.002331.
5
Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.源自小鼠巨噬细胞系P388D1的浆细胞瘤生长因子的纯化及氨基末端序列分析
J Immunol. 1987 Aug 1;139(3):813-7.
6
Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.鉴定人26-kD蛋白,即干扰素β2(IFN-β2),为白细胞介素1和肿瘤坏死因子诱导产生的一种B细胞杂交瘤/浆细胞瘤生长因子。
J Exp Med. 1987 Mar 1;165(3):914-9. doi: 10.1084/jem.165.3.914.
7
Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.肾移植排斥反应中血清恶病质素/肿瘤坏死因子α水平升高。
J Exp Med. 1987 Oct 1;166(4):1132-7. doi: 10.1084/jem.166.4.1132.
8
Construction of rat-mouse T cell hybridomas that express regulatable rat interleukin 2 receptor.表达可调节大鼠白细胞介素2受体的大鼠-小鼠T细胞杂交瘤的构建。
J Immunol. 1986 Sep 1;137(5):1557-63.
9
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6).
Science. 1988 Jan 29;239(4839):502-4. doi: 10.1126/science.2829354.
10
Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.血浆异常凝血酶原(去γ-羧基凝血酶原)作为肝细胞癌的标志物。
Cancer. 1988 Apr 15;61(8):1621-8. doi: 10.1002/1097-0142(19880415)61:8<1621::aid-cncr2820610820>3.0.co;2-c.